Zaman K, Schuind AE, Adjei S, Antony K, et al. Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial. Vaccine 2024 Mar 1:S0264-410X(24)00251-2. doi: 10.1016/j.vaccine.2024.
PMID: 38431444